GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 7 filers reported holding GLAXOSMITHKLINE PLC in Q2 2024. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $610,000 | -22.2% | 15,620 | -29.4% | 0.53% | -18.2% |
Q4 2017 | $784,000 | -19.3% | 22,120 | -7.7% | 0.64% | -22.4% |
Q3 2017 | $972,000 | -25.3% | 23,965 | -20.7% | 0.83% | -21.4% |
Q2 2017 | $1,302,000 | +0.6% | 30,215 | -1.6% | 1.06% | -1.7% |
Q1 2017 | $1,294,000 | +7.4% | 30,715 | -1.9% | 1.07% | +4.0% |
Q4 2016 | $1,205,000 | -13.5% | 31,315 | -3.1% | 1.03% | -11.1% |
Q3 2016 | $1,393,000 | -0.5% | 32,315 | 0.0% | 1.16% | +1.5% |
Q2 2016 | $1,400,000 | +5.3% | 32,315 | -1.5% | 1.14% | -6.5% |
Q1 2016 | $1,330,000 | +0.5% | 32,815 | 0.0% | 1.22% | +5.5% |
Q4 2015 | $1,324,000 | -0.9% | 32,815 | -5.6% | 1.16% | -4.0% |
Q3 2015 | $1,336,000 | -13.6% | 34,765 | -6.5% | 1.21% | -2.5% |
Q2 2015 | $1,547,000 | -9.8% | 37,165 | 0.0% | 1.24% | -7.0% |
Q1 2015 | $1,715,000 | +5.0% | 37,165 | -2.8% | 1.33% | +7.1% |
Q4 2014 | $1,634,000 | -24.3% | 38,235 | -18.6% | 1.24% | -24.4% |
Q3 2014 | $2,159,000 | +263.5% | 46,985 | +322.7% | 1.64% | +272.8% |
Q2 2014 | $594,000 | – | 11,115 | – | 0.44% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |